socalTECH

FEBRUARY 24, 2014

San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. Cloudant had been backed by Avalon Ventures, Devonshire Investors, In-Q-Tel, Rackspace, Samsung, and Toba Capital, and had only raised around $14.0M

Avalon 173

Avalon IBM IBM San Diego 173

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

socalTECH

JANUARY 17, 2017

AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

NOVEMBER 3, 2014

Proximal Data was venture backed by Divergent Ventures and Avalon Ventures, and had only announced around $5M in funding. proximal data samsung electronics merger acquisition cache caching software storage memory hardware' Financial terms of the buy were not announced. READ MORE>>.

Avalon 138

Avalon San Diego Software Acquisition 138

socalTECH

JULY 16, 2013

According to Core Innovation Capital , it has moved its offices to Los Angeles from New York City, to be closer to potential investments in its focus area of funding companies serving underbanked consumers in America. The fund has not yet announced local investments, but has been actively talking to companies fitting its investment profile.

Capital 174

Capital Southern California Avalon SoCalTech 174

socalTECH

APRIL 1, 2013

San Diego-based Proximal Data , which develops serve-side caching software for accelerating I/O access to virtualized machines, said this morning that it has raised $2M in a Series B round of funding. The funding came from Divergent Ventures, along with existing investors Avalon Ventures. The firm is led by Rory Bolt.

Software 124

Software Avalon San Diego Design 124

socalTECH

JANUARY 26, 2017

AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. Anaptys priced its IPO on Wednesday night at $15.00 per share, at the midpoint of its $14.00 estimated IPO range, and closed the day at $17.00 READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100